Bronchodilator effect of zafirlukast in subjects with chronic obstructive pulmonary disease

Publisher： Elsevier

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.16, Iss.5, 2003-10, pp. : 307-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Bronchodilator Test with Increasing Doses of Terbutaline in Chronic Obstructive Pulmonary Disease Patients

By Rodríguez-Carballeira M. Heredia J.L. Rué M. Quintana S. Gómez L.

Pulmonary Pharmacology & Therapeutics, Vol. 14, Iss. 1, 2001-01 ,pp. : 61-65

Academic Press

Access to resources Recommend Favorite

Bronchodilator Combination Therapy for the Treatment of Chronic Obstructive Pulmonary Disease

Current Clinical Pharmacology, Vol. 6, Iss. 1, 2011-01 ,pp. : 48-61

Bentham Science Publishers

Access to resources Recommend Favorite

Optimum Bronchodilator Combinations in Chronic Obstructive Pulmonary Disease: What is the Current Evidence?

By Miles Matthew C.

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 301-308

Adis International

Access to resources Recommend Favorite

Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease

By ZuWallack Alicia R ZuWallack Richard L

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1827-1835

Informa Healthcare

Access to resources Recommend Favorite

Stem Cell Therapy in Chronic Obstructive Pulmonary Disease. Seeking the Prometheus Effect

Current Drug Targets, Vol. 14, Iss. 2, 2013-02 ,pp. : 246-252

Bentham Science Publishers

Access to resources Recommend Favorite